Pancreas Cancer News and Archives
	Epeius Biotechnologies Corporation Gains FDA Orphan Drug Approval for REXIN-G, the World's First Targeted Injectable Gene Therapy Vector, for Pancreatic Cancer September 8, 2003 Epeius Biotechnologies Corporation today announced that the FDA has approved REXIN-G, the world's first tumor-targeted injectable gene therapy vector, as an orphan drug for pancreatic cancer. The FDA's decision to approve REXIN-G was based on objective demonstrations of medical plausibility of REXIN-G as an effective treatment for pancreatic cancer. ...full article
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org